Eravacycline

ATC J01AA13 · 4 markets · 4 records

Eravacycline 4 markets · 4 records Forms

GB 1 records · 1 strengths

100 mginjectionXerava 100mg powder for concentrate for solution for infusion vials also in ES

ES 1 records · 1 strengths

100 mginjectionXerava also in GB

HK 1 records · 1 strengths

Records without a stated strength · 1 XERAVA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Xerava

Side-by-side table

Strength / form / release	GB	ES	HK	EU
100 mg injection	Xerava 100mg powder for concentrate for solution for infusion vials	Xerava	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	XERAVA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG	Xerava

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.